Transcriptomic analysis of human primary T cells after short-term leucine-deprivation and evaluation of kinase GCN2's role in regulating differential gene expression
Related Experiment Video
Updated: May 27, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Aurore Dougé1,2, Gwendal Cueff3, Céline Keime4
1Service d'oncologie médicale, CHU Gabriel Montpied, Clermont-Ferrand, France.
Abstract:
Chimeric Antigen Receptor T (CAR-T) cells offer a promising strategy for cancer treatment. These CAR-T cells are either autologous or allogeneic T cells that are genetically modified to express a chimeric antigen receptor targeting a specific tumor antigen. Ongoing research aims to optimize the CAR-T cell efficacy, including strategies to modulate their metabolism. One such approach involves inducing transgene expression by activating the GCN2 kinase signaling pathway through dietary deprivation of an essential amino acid. In this study, we investigated the general impact of a 6-hour leucine deprivation on primary activated human T cells using RNA-seq technology. Our analysis identified 3,431 differentially expressed genes between T cells cultured in regular medium and those cultured in leucine-deprived medium. Gene Set Enrichment Analysis revealed that "TNFα signaling via NFκB", "interferon-γ response", and "unfolded protein response" gene sets were positively enriched, while "mTORC1 signaling", "Myc targets", and "oxidative phosphorylation" gene sets were negatively enriched. To further evaluate the involvement of GCN2 kinase in regulating the differential gene expression during the 6-hour leucine deprivation, T cells were cultured with or without a GCN2 inhibitor. We found that 59% of the differentially expressed genes in our dataset were dependent on the kinase GCN2 (n = 2028), with 1,140 up-regulated and 888 down-regulated genes. These findings suggest a promising strategy to enhance CAR-T cell efficacy by combining short amino acid starvation with transient overexpression of a target gene.
Insights
Short leucine deprivation in T cells enhances gene expression via GCN2 kinase. This metabolic modulation strategy shows promise for improving Chimeric Antigen Receptor T (CAR-T) cell cancer therapies.
Area of Science:
- Immunology
- Cellular Metabolism
- Cancer Therapy
Background:
- Chimeric Antigen Receptor T (CAR-T) cells are a key cancer treatment strategy.
- Optimizing CAR-T cell efficacy involves modulating their metabolism.
- Activating GCN2 kinase via amino acid deprivation can induce transgene expression.
Purpose of the Study:
- Investigate the impact of leucine deprivation on human T cells.
- Determine the role of GCN2 kinase in differential gene expression.
- Evaluate amino acid starvation as a method to enhance CAR-T cell efficacy.
Main Methods:
- Primary human T cells were cultured with or without leucine.
- RNA-sequencing technology was used to analyze gene expression changes.
- GCN2 kinase inhibitor was used to assess kinase dependency.
Main Results:
- Leucine deprivation altered 3,431 genes in T cells.
- Key pathways like TNFα signaling and interferon-γ response were enriched.
- GCN2 kinase mediated 59% of the observed gene expression changes.
Conclusions:
- Short-term leucine deprivation significantly impacts T cell gene expression.
- GCN2 kinase plays a crucial role in mediating these metabolic responses.
- Combining amino acid starvation with transient gene overexpression is a promising strategy for CAR-T cell enhancement.

